Gastric (Stomach) Cancer Clinical Trials

11 recruiting

Gastric (Stomach) Cancer Trials at a Glance

11 actively recruiting trials for gastric (stomach) cancer are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 6 trials, with the heaviest enrollment activity in Zhengzhou, Tongling, and Beijing. Lead sponsors running gastric (stomach) cancer studies include Fudan University, Cedars-Sinai Medical Center, and Beijing Tide Pharmaceutical Co., Ltd.

Browse gastric (stomach) cancer trials by phase

Treatments under study

About Gastric (Stomach) Cancer Clinical Trials

Looking for clinical trials for Gastric (Stomach) Cancer? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastric (Stomach) Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastric (Stomach) Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria

Gastric CancerGastric (Stomach) CancerGastric Cancer (Diagnosis)
Société Algérienne de Formation et Recherche en Oncologie1,000 enrolled15 locationsNCT07481110
Recruiting
Phase 2

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Breast CancerSarcomaLung Cancer+2 more
University of California, Irvine24 enrolled1 locationNCT07447050
Recruiting

An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori

Gastric (Stomach) CancerHelicobacter Infection
Fudan University3,000 enrolled1 locationNCT06896370
Recruiting

Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis

Gastric (Stomach) Cancer
Fudan University15,000 enrolled1 locationNCT06943807
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Phase 1Phase 2

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Endometrial CancerGastric (Stomach) CancerNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Beijing Tide Pharmaceutical Co., Ltd266 enrolled3 locationsNCT07371663
Recruiting
Phase 1Phase 2

Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer

Gastric (Stomach) CancerGastric AdenocarcinomaGEJ Adenocarcinoma+1 more
Henan Cancer Hospital45 enrolled1 locationNCT07334431
Recruiting

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Esophageal CancerGastric (Stomach) CancerStomach Cancer+2 more
Stanford University100 enrolled1 locationNCT01048281
Recruiting
Phase 2

The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial

Gastric (Stomach) CancerImmunotherapyBiological Therapy
Chinese PLA General Hospital90 enrolled1 locationNCT07212933
Recruiting
Phase 1Phase 2

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

Gastric (Stomach) CancerStomach Neoplasm
Asan Medical Center57 enrolled2 locationsNCT06732856
Recruiting
Phase 1Phase 2

XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC

Gastric (Stomach) Cancer
West China Hospital57 enrolled2 locationsNCT06742411